TR199902410A2 - Anti-Moroccan Antibodies - Google Patents
Anti-Moroccan AntibodiesInfo
- Publication number
- TR199902410A2 TR199902410A2 TR1999/02410A TR9902410A TR199902410A2 TR 199902410 A2 TR199902410 A2 TR 199902410A2 TR 1999/02410 A TR1999/02410 A TR 1999/02410A TR 9902410 A TR9902410 A TR 9902410A TR 199902410 A2 TR199902410 A2 TR 199902410A2
- Authority
- TR
- Turkey
- Prior art keywords
- antibodies
- moroccan
- fas
- anomalies
- mice
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
- C07K16/18—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans
- C07K16/28—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants
- C07K16/2878—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants against the NGF-receptor/TNF-receptor superfamily, e.g. CD27, CD30, CD40, CD95
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K2317/00—Immunoglobulins specific features
- C07K2317/20—Immunoglobulins specific features characterized by taxonomic origin
- C07K2317/24—Immunoglobulins specific features characterized by taxonomic origin containing regions, domains or residues from different species, e.g. chimeric, humanized or veneered
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K2317/00—Immunoglobulins specific features
- C07K2317/50—Immunoglobulins specific features characterized by immunoglobulin fragments
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K2317/00—Immunoglobulins specific features
- C07K2317/70—Immunoglobulins specific features characterized by effect upon binding to a cell or to an antigen
- C07K2317/75—Agonist effect on antigen
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K2317/00—Immunoglobulins specific features
- C07K2317/70—Immunoglobulins specific features characterized by effect upon binding to a cell or to an antigen
- C07K2317/76—Antagonist effect on antigen, e.g. neutralization or inhibition of binding
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Immunology (AREA)
- Organic Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Biophysics (AREA)
- Biochemistry (AREA)
- Genetics & Genomics (AREA)
- Medicinal Chemistry (AREA)
- Molecular Biology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Life Sciences & Earth Sciences (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
Abstract
Anti-F.A.S. antibodies can get in a cross reaction with both human and mice F.A.S. and they are used in the treatment of the problems caused by the anomalies in the FAS/FAS related systems.
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
TR1999/02410A TR199902410A2 (en) | 1999-09-29 | 1999-09-29 | Anti-Moroccan Antibodies |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
TR1999/02410A TR199902410A2 (en) | 1999-09-29 | 1999-09-29 | Anti-Moroccan Antibodies |
Publications (1)
Publication Number | Publication Date |
---|---|
TR199902410A2 true TR199902410A2 (en) | 2001-07-23 |
Family
ID=21622180
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
TR1999/02410A TR199902410A2 (en) | 1999-09-29 | 1999-09-29 | Anti-Moroccan Antibodies |
Country Status (1)
Country | Link |
---|---|
TR (1) | TR199902410A2 (en) |
-
1999
- 1999-09-29 TR TR1999/02410A patent/TR199902410A2/en unknown
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CY2019018I2 (en) | ANTIBODY MOLECULES SPECIFIC TO HUMAN TUMOR NECROSION FACTOR ALPHA, AND USE THEREOF | |
CY2012002I1 (en) | HUMAN CTLA-4 ANTIBODIES AND USES THEREOF | |
ES2124209T3 (en) | REAGENT IMPROVED MONOCLONAL ANTIBODIES WITH CAQUECTINE. | |
DE69813152T2 (en) | Medical robe with adhesive closure | |
DE69940656D1 (en) | Disposable diaper with mechanical fasteners | |
DE69711939T2 (en) | ABSORBENT PRODUCT WITH LATCHES | |
DE60022930D1 (en) | Disposable diaper with elastic tight edges | |
ID25978A (en) | ANTI-FAS ANTIBODY | |
DE69528624T2 (en) | Anti-Fas antibodies against rheumatic diseases | |
DE60113445D1 (en) | SUBSTANCES WITH BRANCHED LINKERMOLEKÜLEN | |
DE68920624D1 (en) | Human monoclonal antibody, hybridoma that makes it, and pharmaceutical agent. | |
ATE457318T1 (en) | MONOCLONAL ANTIBOD DIRECTED AGAINST THE HUMAN BST2 ANTIGEN | |
ID29614A (en) | APPROACHING METHODS, APARATUS TO ARRANGE LIGHTWEIGHT MEETINGS AND APARATUS TO ARRANGE DISTRIBUTION | |
ATE395363T1 (en) | MONOCLONAL ANTIBODIES TO THE PROTEIN G3BP AND THEIR USES | |
NO981454D0 (en) | Anti-FAS antibodies | |
ATE362490T1 (en) | MONOCLONAL ANTIBODIES AGAINST THE HUMAN LDL RECEPTOR, THEIR PRODUCTION AND USE | |
DE69901076D1 (en) | Linear triene and copolymer thereof | |
DE50011801D1 (en) | Spliceband with fixing aid and its use | |
DE60038761D1 (en) | Computer system with several parallel processors | |
TR199902410A2 (en) | Anti-Moroccan Antibodies | |
ATE189897T1 (en) | ANTIBODIES TO THE PRORENIN PROFRAGMENT, RENINACTIVE SUBSTANCE THAT CONTAINS THEM AND PRORENIN TEST THAT USES THEM | |
ID28905A (en) | ANTIBODIES WITH HIGH AFINITY | |
DE69129582D1 (en) | ANTIBODIES AGAINST HUMAN PLASMIN-ALPHA 2-PLASMININHIBITOR COMPLEX, HYBRIDOMA AND IMMUNOASSAY | |
DE69713159D1 (en) | DISPOSABLE ABSORBENT ITEM WITH USED SIDE PANELS | |
DE19880774D2 (en) | Bed, in particular hospital or nursing bed |